Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ImmunityBio (IBRX) Goodwill (2024 - 2025)

Historic Goodwill for ImmunityBio (IBRX) over the last 2 years, with Q3 2025 value amounting to $910000.0.

  • ImmunityBio's Goodwill rose 111.11% to $910000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $910000.0, marking a year-over-year increase of 111.11%. This contributed to the annual value of $910000.0 for FY2024, which is N/A changed from last year.
  • Per ImmunityBio's latest filing, its Goodwill stood at $910000.0 for Q3 2025, which was up 111.11% from $910000.0 recorded in Q2 2025.
  • ImmunityBio's 5-year Goodwill high stood at $910000.0 for Q4 2024, and its period low was $900000.0 during Q3 2024.